|
Assay Kits |
|
| |
|
| Caspase-1
Colorimetric Assay Kit |
ALX-850-211 |
| Caspase-1
Colorimetric Assay Kit |
BV-K111 |
| Caspase-1
Fluorometric Assay Kit |
ALX-850-212 |
| Caspase-1
Fluorometric Assay Kit |
BV-K110 |
| Caspase-1
Inhibitor Drug Screening Kit |
BV-K151 |
| Caspase-5
Colorimetric Assay Kit |
ALX-850-217 |
| Caspase-5
Colorimetric Assay Kit |
BV-K123 |
| Caspase-5
Fluorometric Assay Kit |
ALX-850-218 |
| Caspase-5
Fluorometric Assay Kit |
BV-K122 |
| Caspase-5
Inhibitor Drug Screening Kit |
BV-K155 |
|
FACE NFkB p65 Profiler |
V13-48300 |
|
FACE NFkB p65 Profiler Chemi |
V13-48400 |
| FAM FLICA
Caspase-1 Assay Kit |
LKT-F0011 |
| FAM FLICA
Caspase-1 Assay Kit (100 Tests) |
ICT-98 |
| FAM FLICA
Caspase-1 Assay Kit (25 Tests) |
ICT-97 |
|
Gelshift NFkB Family (Carcinoma) |
V13-37315 |
|
Gelshift NFkB Family (T Cell Activated) |
V13-37316 |
|
Gelshift NFkB Family (TPA-Inducible) |
V13-37333 |
|
Gelshift NFkB p50 |
V13-37317 |
|
Gelshift NFkB p65 |
V13-37318 |
|
Gelshift NFkB/Rel Family |
V13-37319 |
| IκB Kinase
Detection Set |
PSC-PSI-1821 |
|
LigandLink pLL-1-NFkB p65 Kit |
V13-34004 |
| MDA5 (human)
(IntraCellular) Detection Set [For ELISA Application] |
APO-54N-035 |
|
MDA5 (human) (IntraCellular) ELISA Kit |
APO-54N-039 |
| NF-κB (p50)
(human) Transcription Factor Assay Kit |
CAY-10006912 |
| NF-κB (p65)
Transcription Factor Assay Kit |
CAY-10007889 |
|
Nushift NFkB p50 |
V13-37026 |
| Phospho-IκBα
ActivELISA Assay Kit |
ALX-850-286 |
|
RapidReporter pRR-High-NFkB Assay |
V13-33010 |
|
RapidReporter pRR-High-NFkB vector |
V13-33009 |
| RIG-I (human)
(IntraCellular) ELISA Kit |
APO-54N-045 |
| RIG-I (human)
(IntraCellular) Detection Set [For ELISA Application] |
APO-54N-038 |
|
TransAM Flexi NFkB Family |
V13-43298 |
|
TransAM Flexi NFkB p50 |
V13-41098 |
|
TransAM Flexi NFkB p65 |
V13-40098 |
|
TransAM NFkB Family |
V13-43296 |
|
TransAM NFkB p50 |
V13-41096 |
|
TransAM NFkB p50 Chemi |
V13-41097 |
|
TransAM NFkB p52 |
V13-48196 |
|
TransAM NFkB p52 Chemi |
V13-48197 |
|
TransAM NFkB p65 |
V13-40096 |
|
TransAM NFkB p65 Chemi |
V13-40097 |
|
|
|
|
Peptides and Substrates |
|
| Biotinylated IkB
Kinase Substrate |
BML-P148 |
| Caspase-1
Inhibitor (Z-YVAD-FMK) |
BV-1012 |
| Caspase-1
Substrate (Ac-YVAD-AFC) |
BV-1103 |
| Caspase-5
Inhibitor (Z-WEHD-FMK) |
BV-1100 |
| Caspase-5
Substrate (Ac-WEHD-AFC) |
BV-1101 |
| Caspase-5
Substrate (Ac-WEHD-pNA) |
BV-1102 |
| IKK Peptide
Substrate |
BML-P226 |
| LRRKtide Peptide
Substrate |
BML-P267 |
| LRRKtide Peptide
Substrate (Biotinylated) |
BML-P268 |
| NBD Peptide /
NF-κB Blocker (cell permeable) |
ALX-163-011 |
| SN50 |
ALX-167-024 |
| SN50M Control
Peptide |
ALX-167-025 |
| Z-VRPR-FMK |
ALX-260-166 |
| |
|
|
Recombinant Proteins |
|
| Bcl-10 (human)
(recombinant) |
JBS-PR-769 |
| Caspase-1
(active) (human) (recombinant) |
ALX-201-056 |
| Caspase-1
(active) (human) (recombinant) |
BV-1081 |
| Caspase-1
(active) (mouse) (recombinant) |
BV-1181 |
| Caspase-1 siRNA
Vector |
BV-9501 |
| Caspase-5
(active) (human) (recombinant) |
ALX-201-094 |
| Caspase-5
(active) (human) (recombinant) |
BV-1085 |
| IL-1RAcP
(human):Fc (human) (recombinant) |
ALX-522-143 |
| IκBα (human)
(recombinant) |
BML-SE263 |
| IκBα (human)
(recombinant) (GST) |
BML-UW9970 |
| IκBα (Untagged)
(human) (recombinant) |
BML-UW9975 |
| NF-κB (p50)
(human) (recombinant) (GST) |
CAY-10009818 |
| NF-κB (p50)
(human) (recombinant) (His) |
ALX-201-285 |
| NF-κB (p65)
(human) (recombinant) (His) |
ALX-201-284 |
| NF-κB p50
(human) (recombinant) Western Ready Control |
CAY-10010184 |
| NF-κB p50
Subunit (35-381) (human) (recombinant) (GST) |
BML-UW9980 |
| NF-κB p50
Subunit (35-381) (Untagged) (human) (recombinant) |
BML-UW9985 |
| NF-κB p65
Subunits (12-317) (human) (recombinant) (GST) |
BML-UW9990 |
| NF-κB p65
Subunits (12-317) (Untagged) (human) (recombinant) |
BML-UW9995 |
| Positive Control
(Cell Lysate) for Antibodies to Asc (human) |
ALX-840-602 |
| Positive Control
(Cell Lysate) for Antibodies to RIG-I (human) |
ALX-840-609 |
| Positive Control
(Cell Lysate) for Antibodies to CARMA1 (human) |
ALX-840-606 |
| Positive Control
(Cell Lysate) for Antibodies to NALP1 (human) |
ALX-840-603 |
|
Recombinant NFkB p50 protein |
V13-31101 |
|
Recombinant NFkB p65 protein |
V13-31102 |
| Ribosomal
Protein S3 (human) (recombinant) |
ALX-201-410 |
| Ribosomal
Protein S3 (human) (recombinant) (His) |
ALX-201-408 |
| RIPK2 (active) |
BV-7747 |
| RIPK2 (human)
(recombinant) |
BML-SE397 |
| |
|
|
Antibodies |
|
| MAb to A20
(human) (8E8.38), Mouse IgG1 |
ALX-804-137 |
| MAb to Bcl-10
(Carmen-1), Rat IgM |
ALX-804-134 |
| MAb to Bcl-10
(human) (phosphorylated) (pSer138) (6D3), Mouse IgG1 |
NT-0137 |
| MAb to Bcl-3
(Ham150-3.5) |
ABR-MA1-950 |
| MAb to Cardif
(human) (Adri-1), Mouse IgG2b |
ALX-804-847 |
| MAb to Caspase-1
(mouse) (1H11), Rat IgG1 |
ALX-804-530 |
| MAb to Caspase-1
(mouse) (4G8), Rat IgG1 |
ALX-804-531 |
| MAb to IKKα
(14A231), Mouse IgG1 |
ALX-804-236 |
| MAb to IKKβ
(human) (10AG2), Mouse IgG1 |
ALX-804-237 |
| MAb to IKKγ
(human) (46B844), Mouse IgG1 |
ALX-804-424 |
| MAb to IKKε
(72B587), Mouse IgG2akappa |
ALX-804-321 |
| MAb to IκBα |
BV-3315 |
| MAb to IκBα
(6A920), Mouse IgG1 |
ALX-804-209 |
| MAb to IκBα
(cleaved) (human) (5D1623), Mouse IgG1 |
ALX-804-440 |
| MAb to IκBα
(human) (phosphorylated) (pSer32/36) (39A1431), Mouse IgG1 |
ALX-804-235 |
| MAb to NALP1
(human) (Nalpy1-4), Mouse IgG1 |
ALX-804-803 |
| MAb to NALP3
(human) (Nalpy3-a), Mouse IgG1 |
ALX-804-818 |
| MAb to NALP3
(human) (Nalpy3-b), Mouse IgG1 |
ALX-804-819 |
| MAb to NF-κB
(human) (NF3A11), Rat IgG2a |
ALX-804-043 |
| MAb to NF-κB
(human) (NF5E6), Rat IgG1 |
ALX-804-044 |
| MAb to NF-κB
(p65) (112A1021), Mouse IgG1 |
ALX-804-361 |
|
MAb to NFκBp65 |
BV-3012 |
| MAb to RIG-I
(Alme-1), Mouse IgG1 |
ALX-804-849 |
| MAb to RIP3
(human) (Rippy-3), Mouse IgG1 |
ALX-804-155 |
| MAb to
TANK-binding Kinase 1 (108A429), Mouse IgG1 |
ALX-804-372 |
| MAb to Ribosomal
Protein S3 (human) (RP159-1), Mouse IgG1 |
ALX-804-733 |
| MAb to RIP2
(human) (Nick-1), Rat IgG2a |
ALX-804-139 |
| Monoclonal
Antibody to MDA5 (human) (Hely-1), Mouse IgG1 |
ALX-804-863 |
| PAb to ABIN-2,
From rabbit. |
ALX-210-370 |
| PAb to Act1/CIKS
(human) (CT), From rabbit. |
PSC-2499 |
| PAb to Act1/CIKS
(human) (NT), From rabbit. |
PSC-2501 |
| PAb to Asc |
BV-3291 |
| PAb to ASC
(human), From rabbit. |
PSC-2287 |
| PAb to Bcl-10
(human) (NT), From rabbit. |
PSC-2161 |
| PAb to Bcl-3 |
BV-3407 |
| PAb to CARD9
(human), From rabbit. |
PSC-2515 |
| PAb to Cardif
(human) (AT107), From rabbit. |
ALX-210-929 |
| PAb to CARMA1
(AL220), From rabbit. |
ALX-210-903 |
| PAb to CARMA1,
From rabbit. |
PSC-3189 |
| PAb to Caspase-1
(human) (CT), From rabbit. |
PSC-3459 |
| PAb to Caspase-1
(human) (IN), From rabbit. |
PSC-3463 |
| PAb to
Caspase-1, From rabbit. |
ALX-210-804 |
| PAb to
Caspase-1, From rabbit. |
BV-3019 |
| PAb to Caspase-5
(human) (IN), From rabbit. |
PSC-3457 |
| PAb to Caspase-5
(human) (NT), From rabbit. |
PSC-3455 |
| PAb to
Caspase-5, From rabbit. |
ALX-210-809 |
| PAb to
Caspase-5, From rabbit. |
BV-3029 |
| PAb to CIKS/Act1 |
BV-3314 |
| PAb to FAF1 |
BV-3346 |
| PAb to FAF1
(CT), From rabbit. |
PSC-3993 |
| PAb to IKAP
(CT), From rabbit. |
PSC-2337 |
| PAb to IKKα |
BML-SA301 |
| PAb to IKKα
(human) (C1), From rabbit. |
PSC-2025 |
| PAb to
IKKα/IKK-1 |
BV-3185 |
| PAb to IKKβ |
BML-SA302 |
| PAb to IKKγ
(CT), From rabbit. |
PSC-2335 |
| PAb to IκBα |
BV-3252 |
| PAb to IκBα
(C-CT) |
BML-SA303 |
| PAb to IκBα
(human), From rabbit. |
ASB-P100940 |
| PAb to IκBα
(phosphorylated) (pSer32/36) |
BML-SA412 |
| PAb to IκBβ
(NFκB Regulatory Subunit) |
BML-SA238 |
| PAb to LRRK2
(human) (AT106), From rabbit. |
ALX-210-928 |
| PAb to MAVS
(IN), From rabbit. |
PSC-4055 |
| PAb to MAVS
(NT), From rabbit. |
PSC-4053 |
| PAb to MDA5
(CT), From rabbit. |
PSC-4037 |
| PAb to MDA5
(human) (AT113), From rabbit. |
ALX-210-935 |
| PAb to MDA5
(IN), From rabbit. |
PSC-4039 |
| PAb to MDA5
(mouse) (AL180), From rabbit. |
ALX-210-352 |
| PAb to NALP1
(human) (AL176), From rabbit. |
ALX-210-904 |
| PAb to NALP12
(human) (AL236), From rabbit. |
ALX-210-958 |
| PAb to NALP12
(mouse) (AT141), From rabbit. |
ALX-210-967 |
| PAb to NF-κB
(p100) (human), From rabbit. |
ASB-ARP32043 |
| PAb to NFκB (p50
Subunit) (NT) |
BML-SA170 |
| PAb to NF-κB
(p50), From rabbit. |
ALX-210-576 |
| NF-κB Kit
(Antibodies and Peptides) |
BML-SA174 |
|
NFkB p50 rabbit pAb |
V13-39037 |
|
NFkB p50 rabbit pAb |
V13-39330 |
| PAb to NF-κB p50 |
BV-3354 |
| PAb to NFκB (p65
Subunit) (CT) |
BML-SA171 |
| PAb to NF-κB
(p65) (human), From rabbit. |
ASB-P100779 |
| PAb to NF-κB
(p65), From rabbit. |
ALX-210-574 |
|
NFkB p65 mouse mAb |
V13-40916 |
|
NFkB p65 rabbit pAb |
V13-39038 |
|
NFkB p65 rabbit pAb |
V13-39039 |
|
NFkB p65 rabbit pAb |
V13-39283 |
|
NFkB p65 rabbit pAb |
V13-39369 |
|
NFkB p65 rabbit pAb, sample |
V13-39284 |
|
NFkB p65 rabbit pAb, sample |
V13-39370 |
| PAb to NFκBp65 |
BV-3038 |
|
NFkB/Rel Family Antibody Screening Kit |
V13-39074 |
| PAb to NFκB
c-rel |
BML-SA172 |
| PAb to NIK |
BV-3193 |
| PAb to NIK
(human) (CT), From rabbit. |
PSC-1129 |
| PAb to
Pannexin-1 (human) (AT124), From rabbit. |
ALX-210-949 |
| PAb to Pyrin
(human) (AL196), From rabbit. |
ALX-210-946 |
| PAb to RICK ,
From rabbit. |
CAY-160785 |
| PAb to RIG-I
(human) (AT111), From rabbit. |
ALX-210-932 |
| PAb to RIP |
BV-3279 |
| PAb to RIP
(human), From rabbit. |
ASB-AVARP02038 |
| PAb to RIP2
(human) (CT), From rabbit. |
PSC-2183 |
| PAb to RIP3 |
BV-3293 |
| PAb to RIP3,
From rabbit. |
PSC-2283 |
| PAb to TANK |
BV-3348 |
| PAb to TANK
(CT), From rabbit. |
PSC-3877 |
| PAb to TANK (NT)
(human), From rabbit. |
PSC-3879 |
| PAb to TMS1 |
BV-3560 |
| PAb to ZUD
(AT116), From rabbit. |
ALX-210-939 |
| PAb to κB Ras
(IN), From rabbit. |
PSC-2491 |
| PAb to κB Ras1
(CT), From rabbit. |
PSC-2493 |
| PAb to κB Ras2
(CT), From rabbit. |
PSC-2495 |
| PAb to Asc
(AL177), From rabbit. |
ALX-210-905 |
| PAb to CYLD
(human) (AF888), From rabbit. |
ALX-210-910 |
| PAb to IKKε
(human) (CT), From rabbit. |
PSC-2329 |
| PAb to NALP1
(human) (CT) (Bur 242), From rabbit. |
ALX-210-017 |
| PAb to NALP1
(human) (CT), From rabbit. |
PSC-3037 |
| PAb to NALP1
(human) (NT) (Bur 241), From rabbit. |
ALX-210-018 |
| PAb to NALP2
(CT), From rabbit. |
PSC-3027 |
| PAb to Ribosomal
Protein S3 (human), From rabbit. |
ALX-210-481 |
| PAb to RIP2
(NT), From rabbit. |
PSC-2075 |
| PAb to
ELKS/RAB6-interacting/CAST Family Member 1, From rabbit. |
CVL-PAB0360 |
| PAb to IKKα
(human) (C2), From rabbit. |
PSC-2115 |
| PAb to IKKα
(human) (C3), From rabbit. |
PSC-2117 |
| PAb to IKKβ
(human) (C3), From rabbit. |
PSC-2121 |
| PAb to Protein
LYRIC, From rabbit. |
CVL-PAB0488 |
|
PAb to TANK-binding Kinase 1 (CT), From rabbit. |
PSC-2351 |
| Polyclonal
Antibody to TRB-3 (human), From rabbit. |
ALX-210-462 |
| |
|
|
Substances |
|
| ()-Hesperetin |
ALX-385-011 |
|
10Z-Hymenialdisine |
ALX-350-289 |
|
3-O-Acetyl-11-keto-β-boswellic acid |
ALX-350-310 |
|
3-O-Acetyl-β-boswellic acid |
ALX-350-308 |
| 5-Aminosalicylic
acid |
ALX-430-110 |
| 5-Aminosalicylic
Acid |
CAY-70265 |
| 5-Aminosalicylic
acid |
LKT-A5035 |
| A77 1726 |
ALX-430-096 |
| Acetylsalicylic
acid |
LKT-A0819 |
| Adenosine
5'-triphosphate . disodium salt ; ATP . 2Na |
ALX-480-021 |
| AICAR |
BML-EI330 |
| AICAR |
CAY-10010241 |
| Anandamide |
BML-FA017 |
| Anandamide |
ALX-340-029 |
| Arachidonoyl
Ethanolamide |
CAY-90050 |
| Arachidonyl
Ethanolamide-d8 |
CAY-390050 |
| Aspirin |
ALX-430-115 |
| Aspirin |
CAY-70260 |
| BAY 11-7082 |
BML-EI278 |
| BAY 11-7082 |
ALX-270-219 |
| BAY 11-7085 |
BML-EI279 |
| BAY 11-7085 |
ALX-270-220 |
| BAY-11-7082 |
CAY-10010266 |
| Betulinic acid |
BML-AP301 |
| Betulinic acid |
BV-1552 |
| Betulinic acid
(~95%) |
ALX-350-298 |
| Betulinic acid
(high purity) |
ALX-350-277 |
| Butein |
ALX-350-246 |
| Caffeic acid
ethyl ester |
ALX-270-480 |
| Caffeic acid
n-octyl ester |
ALX-350-278 |
| Caffeic acid
phenylethyl ester |
ALX-270-244 |
| Calyculin A |
BML-EI192 |
| Calyculin A |
ALX-350-014 |
| Calyculin A |
BV-1562 |
| Calyculin A |
LKT-C0346 |
| CAPE |
BML-FR102 |
| CAY10470 |
CAY-10006734 |
| CAY10575 |
CAY-10011248 |
| CAY10576 |
CAY-10011249 |
| Celastrol |
ALX-350-332 |
| Celastrol |
CAY-70950 |
| Curcumin |
BML-EI135 |
| Curcumin |
CAY-81025 |
| Curcumin |
LKT-C8069 |
| Curcumin (high
purity) |
ALX-350-028 |
| Curcumin
(technical grade) |
CAY-81025.1 |
|
D-erythro-Sphingosine chloride, N,N,N-Trimethyl- |
ALX-306-022 |
|
Diethyldithiocarbamic acid . sodium salt . trihydrate (high purity) |
ALX-400-003 |
| Diethylmaleate |
ALX-280-017 |
| Emodin |
LKT-E5057 |
| Emodin ;
6-Methyl-1,3,8-trihydroxyanthraquinone |
ALX-350-057 |
| Epoxomicin |
BML-PI127 |
| Epoxomicin |
ALX-350-254 |
| Epoxomicin |
CAY-10007806 |
| Erythromycin |
ALX-380-274 |
| Erythromycin |
LKT-E6994 |
| Erythromycin .
thiocyanate |
LKT-E6996 |
| Erythromycin
ethylsuccinate |
LKT-E6995 |
| FK-506 |
BV-1563 |
| FK-506 |
CAY-10007965 |
| FK506 ;
Tacrolimus |
ALX-380-008 |
| Gemfibrozil |
LKT-G1749 |
| Harpagoside |
ALX-350-333 |
| Helenalin |
BML-EI301 |
| Helenalin |
ALX-350-120 |
| Hesperetin |
CAY-10006084 |
| Hesperetin |
LKT-H1672 |
| Hymenialdisine |
BML-EI333 |
| IKK-NBD Control
Peptide |
BML-P608 |
| IKK-NBD Peptide |
BML-P607 |
| Imiquimod |
BML-CT106 |
| Imiquimod |
ALX-420-039 |
| Imiquimod |
LKT-I5034 |
| Lactacystin |
BML-PI104 |
| Lactacystin |
CAY-70980 |
| Lactacystin |
LKT-L0107 |
| Lactacystin
(native) |
ALX-350-245 |
| Lactacystin
(synthetic) |
ALX-350-260 |
| Leflunomide |
LKT-L1817 |
| Leflunomide ;
HWA486 |
ALX-430-095 |
| MG132 |
CAY-10012628 |
| MG-132 |
BML-PI102 |
| MG-132 |
BV-1703 |
| MG-132 ;
Z-LLL-CHO |
ALX-260-092 |
| Monosodium urate
(crystals) |
ALX-400-047 |
| Morin |
ALX-385-016 |
| Myricetin |
ALX-385-012 |
| Myricetin |
LKT-M9367 |
| NF-κB SN50 Cell
Permeable Inhibitory Peptide |
BML-P600 |
| NF-κB SN50M Cell
Permeable Control Peptide |
BML-P601 |
| Nigericin |
LKT-N3225 |
| Nigericin .
sodium salt |
BML-CA421 |
| Nigericin .
sodium salt |
ALX-380-050 |
|
n-Octyl-3,4-dimethylcaffeate |
LKT-O1177 |
|
n-Octyl-3-methylcaffeate |
LKT-O1178 |
|
n-Octyl-4-methylcaffeate |
LKT-O1179 |
| n-Octylcaffeate |
LKT-O1176 |
| N-Oleoyldopamine |
BML-VR102 |
| N-Oleoyldopamine |
ALX-550-398 |
| Panepoxydone |
ALX-350-109 |
| Parthenolide |
BML-T113 |
| Parthenolide |
ALX-350-258 |
| Parthenolide |
LKT-P0270 |
| Phenethyl
caffeate |
LKT-P2400 |
| Phenethyl
Caffeiate |
CAY-70750 |
| PPM-18 ;
2-Benzoylamino-1,4-naphthoquinone |
ALX-270-458 |
|
Pyrrolidinedithiocarbamic acid . ammonium salt |
ALX-400-002 |
| QNZ |
BML-EI352 |
| R-848 |
ALX-420-038 |
| Radicicol |
BML-EI285 |
| Radicicol |
ALX-380-092 |
|
Radicicol |
LKT-R0212 |
| Rocaglamide |
ALX-350-121 |
| Rocaglamide AL |
ALX-350-140 |
| Rocaglamide C |
ALX-350-141 |
| Rocaglamide I |
ALX-350-142 |
| Rocaglamide J |
ALX-350-143 |
| Rocaglaol |
ALX-350-135 |
| Sauchinone |
ALX-350-116 |
| SC-514 |
BML-EI343 |
| Sodium
salicylate |
ALX-430-116 |
| Sulindac |
ALX-430-105 |
| Sulindac |
CAY-10004386 |
| Sulindac |
LKT-S8145 |
| Sulindac sulfide |
BML-AP200 |
| Sulindac sulfide |
ALX-430-106 |
| Sulindac sulfide |
LKT-S8147 |
| Sulindac sulfone |
BML-AP201 |
| Sulindac sulfone |
ALX-430-107 |
| Sulindac sulfone |
LKT-S8146 |
| Tacrolimus |
LKT-T0008 |
| Trichodion |
ALX-350-261 |
| Triptolide |
BML-AP304 |
| Triptolide |
LKT-T7035 |
| Triptolide ;
PG490 |
ALX-350-259 |
| Wedelolactone |
BML-EI316 |
| Withaferin A |
BML-CT104 |
| Withaferin A |
ALX-350-153 |
| Withaferin A |
LKT-W3576 |
